克洛丹
医学
免疫疗法
癌症
内科学
回顾性队列研究
肿瘤科
紧密连接
生物
细胞生物学
作者
Changsong Qi,Xiaoyi Chong,Ting Zhou,Mingyang Ma,Jifang Gong,Miao Zhang,Jian Li,Jun Xiao,Xiaohui Peng,Zhen Liu,Zonghai Li,Lin Shen,Xiaotian Zhang
标识
DOI:10.21147/j.issn.1000-9604.2024.01.08
摘要
CLDN18.2-positive GC is associated with poor prognosis and worse immunotherapeutic outcomes. The combination of anti-CLDN18.2 therapy, anti-PD-L1/PD-1 therapy, and chemotherapy for GC requires further investigation.
科研通智能强力驱动
Strongly Powered by AbleSci AI